| ADTX 0.01 127.27% | GDC 0.0181 -15.02% | SOXS 3.59 -19.51% | GPUS 0.359 -9.78% | SRXH 0.1245 -37.59% | BITO 8.56 -1.95% | TZA 4.02 -5.85% | SPCX 185 -3.56% | MRVL 310.58 7.27% | CDT 1.02 47.19% | NVDA 210.69 2.95% | INTC 133.99 10.64% | WKSP 0.7379 23.33% | INLF 0.1566 -64.20% | NOK 13.49 -2.46% | AAL 15.99 3.70% | AZTR 0.1717 -15.42% | CAST 8.07 56.70% | CRVO 4.24 11.29% | NFLX 77.38 0.55% | AMC 2.83 6.39% | QS 8.04 16.52% | FLEX 147.61 3.13% | GRAB 3.57 3.48% | SOFI 17.91 2.81% | YYGH 0.0803 -37.70% | AAPL 298.01 0.70% | ATPC 3.88 42.12% | RKLB 107.24 -0.69% | BAC 56.2 -0.58% | LNKS 2.68 67.50% | SMCI 30.66 10.37% | PFE 25.22 -2.70% | SPY 746.74 0.78% | RIG 5.31 -4.84% | AMZN 244.39 2.90% | PLUG 2.85 7.55% | CRWV 117.95 2.38% | TSLL 13.16 1.86% | ONDS 9.27 1.64% | CMCSA 22.43 -1.15% | MU 1133.99 8.70% | TQQQ 82.87 6.87% | BFLY 8.9 55.87% | NVD 4.75 -5.57% | SQQQ 36.75 -7.01% | MSFT 379.4 0.13% | CTSH 43.7 -10.49% | WPRT 2.26 21.51% | T 22.01 -1.92%

Northrop Grumman (NYSE:NOC) Stock Declines Amidst Strong Q1 Earnings and Lowered EPS Guidance

Northrop Grumman (NYSE:NOC) is a global aerospace and defense technology company. It operates in various sectors, including aeronautics, defense systems, and space systems, providing advanced solutions to government and commercial customers. On April 23, 2026, a UBS analyst set a new price target on Northrop Grumman at $745, implying a 26.35% potential upside from its price of $589.65 at the time.

Despite this optimistic target, the company's stock price is currently falling. As highlighted by Benzinga, shares are sinking after Northrop Grumman reported its first-quarter earnings. This recent drop follows a 16% stock decline, which has led some to consider the stock a "Strong Buy," as noted by Seeking Alpha, because it is trading below its perceived value.

The company's first-quarter results were strong, beating analyst expectations. Northrop Grumman reported quarterly earnings of $6.14 per share, which was higher than the consensus estimate of $6.09. The company also posted quarterly sales of $9.88 billion, surpassing the analyst estimate of $9.75 billion and showing a 4.36 percent increase from the same quarter a year ago.

The negative market reaction is tied to the company's forecast for the full year. Northrop Grumman affirmed its 2026 adjusted earnings per share (EPS) guidance to be between $27.40 and $27.90. EPS represents the company's profit per share, and this forecast is below the analyst consensus estimate of $28.01, causing concern among investors.

While the company's sales outlook of $43.50 billion to $44 billion is in line with estimates, the lower earnings guidance suggests a "ramp-up year" with muted margin growth. This short-term outlook contrasts with the view that the stock's recent decline presents a valuable buying opportunity, aligning with the significant upside suggested by the UBS price target.

Published on: April 23, 2026